Chromatin Immunoprecipitation (ChIP) Assays. Where indicated before fixation (1% formaldehyde; 15 min) cells were treated with PMA (100 nM, 90 min) and/or IL-6 (50 ng/ml, 20 min). For ChIP, cells were 125 mM glycine, washed (PBS) and detached in the presence of protease inhibitors: aprotinin (15K U/ml), leupeptin (3 μg/ml), PMSF (300 μM) and pepstatin (1 μg/ml). Cell pellets were then resuspended in sonication buffer (1 % Triton X-100, 0.1 % sodium deoxycholate, 50 mM Tris-HCl pH 8.1, 5 mM EDTA, 150 mM NaCl, protease inhibitors as above) and sonicated on ice for 8 bursts of 10 sec. Cell debris was removed by centrifugation (15000 g, 15 min, 4˚C).
Supernatants were pre-cleared with 40 μl protein G sepharose (50 % slurry). Sheared herring sperm DNA (2 μg) was then added for a further 2 h. Precipitates were washed sequentially for 10 min with sonication buffer, twice with buffer II (1 % Triton X-100, 0.1 % sodium deoxycholate, 50 mM TrisHCl pH 8.1, 5 mM EDTA, 500 mM NaCl, protease inhibitors), once with buffer III (250 mM LiCl, 0.5 % Nonidet P-40, 0.5 % sodium deoxycholate, 10 mM Tris-HCl pH 8.1, 1 mM EDTA, protease inhibitors), and three times with TE buffer containing protease inhibitors. Bead precipitates were eluted twice with 150 μl elution buffer (1 % SDS, 100 mM NaHCO3) and samples incubated (65˚C, 4 h) with 0.3 M NaCl and 3 ng RNase A, following which the samples were left overnight at 45˚C with 75 μg proteinase K. DNA was then purified and qPCR conducted, following methods described. Data is presented as percentage (%) of total input DNA bound.
Antibodies used for ChIP included anti-STAT-1α (C-24; #sc-345X; Santa Cruz Biotech Inc) and anti-pan-Fos, as above. ChIP assays were conducted using primers to amplify a 188 bp sequence in the MMP-3 promoter as follows: forward; 5'-TCCTCTACCAAGACAGGAAGC-3' and reverse;
5'-TTTGTTTGGATCACCCGCAGC-3'. To obtain extracts, cells were grown to 60 % confluence and cultured for a further 24 h in reduced serum (1 %), prior to cytokine treatment. Following fixation and binding, DNA was purified and Q-PCR analysis conducted using SYBR green I following methods described above. The amount of precipitated DNA was calculated as a percentage of input DNA.
Production of the A4 STAT-3 null colon cancer cell line and northern blotting analysis. The STAT-3 gene was knocked out in DLD1 cells by homologous recombination to make the STAT-3-null A4
cell line using pAAV-Neo-loxP similar to the methods described previously
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. A4 cells were then reconstituted to re-express wild-type STAT3 by stable transfection of a retroviral expression vector, which was generated by inserting the human STAT-3 cDNA into the HindIII site of pLEGFP-N1 (Clontech, Palo
Alto, CA). Stably transduced A4 cell pools were selected following treatment with G418 (500 μg/ml). Cells were either treated with IL-6 (200 ng/ml) together with IL-6 soluble receptor (250 ng/ml) or left untreated.
Probes used for analysis of human MMP gene expression were generated by RT-PCR by using gene specific primer sets. Primer sequences were as follows: 5'-ATGGAGGCGCTAATGGCCCGGGGCGCGC-3' (forward) and 5'-GGGTTGCCGCAGCGTGGCTTCCGCA-3' (reverse) for the MMP-1 gene corresponding to 1-615 bp of its coding domains; 5'-ATGAAGAGTCTTCCAATCCTAC-3' (forward) and 5'- 
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